Feeling Fine Is Not Data: How to Catch Silent Aging in Your Gums, Liver, and Cells

Most of us over 40 judge our health by how we feel. The problem is that several of the most consequential aging processes produce no signal you can feel for years: your gums recede in fractions of a millimeter, your liver accumulates fat and early scar tissue without a twinge, and the pace of your cellular aging shifts with no sensation at all. By the time symptoms arrive, you have usually lost the window where change is easiest. This is silent aging, and the answer to it is not anxiety; it is measurement.

Why "no symptoms" is the weakest evidence you own

The three examples in this article share a structure. Each process is common after 40, each advances slowly, each is far more tractable early than late, and each is invisible to introspection. Pain is a late-stage messenger. That is why the practical question is not "do I feel fine?" but "what have I actually measured this year?" Below, the evidence is graded the way we always grade it here: established, emerging, or personal experimentation.

Three processes that advance without warning

Gums: roughly half of adults have recession, and most have never had it measured

Gingival recession, the gradual exposure of the tooth root as gum tissue migrates, affects about 50 percent of US adults aged 18 to 64 and 88 percent of adults over 65 in at least one site, according to the classic prevalence review by Kassab and Cohen in the Journal of the American Dental Association (2003). A 2025 meta-analysis in the Journal of Dentistry found a pooled global prevalence of 81 percent for recession of at least 1 mm. Its close cousin, periodontitis, affected 42 percent of dentate US adults over 30 in the CDC-led NHANES analysis by Eke and colleagues (JADA, 2018).

Two details matter for readers who feel fine. First, recession is usually painless until roots become sensitive, which is late. Second, one recognized contributor is aggressive horizontal brushing with a hard bristle brush; a habit people adopt precisely because they are trying to be diligent. Beyond the mouth, a 2025 American Heart Association scientific statement in Circulation concludes that periodontal disease is associated with atherosclerotic cardiovascular disease, while being explicit that causality is not established and that shared risk factors explain part of the link. Association, not causation; but a measurable, modifiable association.

Liver: normal enzymes can coexist with real disease

Metabolic dysfunction-associated steatotic liver disease (the condition formerly called NAFLD) had a pooled global prevalence of 30 percent in the meta-analysis by Younossi and colleagues in Hepatology (2023), rising to 38 percent in studies from 2016 to 2019. The disease progresses through stages, from simple fat accumulation to inflammation to fibrosis, and the early stages are substantially reversible through weight loss, exercise, and reduced alcohol intake.

Here is the trap: a normal ALT on your annual panel is not a clean bill of health. The 2023 AASLD Practice Guidance (Rinella et al., Hepatology) explicitly moves away from relying on liver enzymes alone and recommends risk stratification with the FIB-4 index, a score computed from four things already on a standard blood panel: age, AST, ALT, and platelet count. A FIB-4 above roughly 1.3 flags the need for further evaluation, typically elastography (FibroScan), in people with metabolic risk factors such as type 2 diabetes, prediabetes, or obesity. This is exactly the "canary in the coal mine" framing Peter Attia uses in his AMA on metabolic liver health: the liver often registers metabolic dysfunction before anything else does.

Cells: epigenetic clocks are becoming useful, and they are still noisy

Can you measure whether your habits are slowing your aging? This is where the newest evidence sits. In August 2026, a study in Nature Medicine introduced TranslAGE, a harmonized database of 51 longitudinal human intervention studies, and tested how 16 prominent epigenetic clocks plus 94 other DNA methylation biomarkers respond to interventions. The headline findings: clocks trained to predict mortality or pace of aging (the GrimAge and DunedinPACE families) responded most strongly and most consistently, and pharmacological and lifestyle interventions drove the largest responses.

This builds on the CALERIE randomized trial, where two years of caloric restriction in 220 adults slowed DunedinPACE by 2 to 3 percent while leaving clocks like PhenoAge and GrimAge essentially unchanged (Waziry et al., Nature Aging, 2023). The caution: Higgins-Chen and colleagues showed in Nature Aging (2022) that technical noise alone can produce deviations of up to 9 years between duplicate tests of the same blood sample on standard clocks. The signal is real; a single consumer test result is not a diagnosis.

A 90-day silent-aging audit, step by step

1. Book a periodontal charting, not just a cleaning. Ask your dentist or hygienist for a full charting: probing depths for each tooth, recession in millimeters, and bleeding on probing. This takes minutes and creates your baseline.
2. Compute your FIB-4 from labs you probably already have. At your next blood draw, make sure AST, ALT, and platelets are included, and ask your clinician to calculate and interpret FIB-4 in the context of your metabolic risk factors. If it is elevated, the usual next step is elastography, not panic.
3. Fix the mechanical inputs while you wait. Switch to a soft-bristle brush with light pressure and small circular strokes; keep flossing. For the liver, the levers with the strongest evidence are weight reduction if needed, regular exercise including resistance training, and limiting alcohol.
4. Decide whether cellular aging tracking is an experiment you want to run. If yes, treat it as n-of-1 research: same laboratory, a pace-of-aging measure such as DunedinPACE, tests spaced at least 6 to 12 months apart, interpreted as a trend across three or more points.

A worked example, composite rather than a real patient: a 52-year-old cyclist who "feels 35" gets charted and finds 3 mm of recession on two teeth with 5 mm pockets, plus a FIB-4 of 1.5. Elastography shows mild stiffness. Twelve months of soft-brush technique, periodontal follow-up, 5 kg of weight loss, and two strength sessions per week later, his observable markers have moved: no bleeding on probing, stable recession, FIB-4 back under 1.3. Nothing about how he felt ever changed. Everything measurable did.

Mistakes to avoid

• Brushing harder to "clean better." Forceful scrubbing with hard bristles is a recognized contributor to recession; the tissue you wear away does not grow back on its own.
• Reading a normal ALT as "my liver is fine." Enzymes can be unremarkable while fibrosis progresses; this is precisely why AASLD guidance is built around FIB-4 and elastography rather than ALT alone.
• Retesting an epigenetic clock every two months. With replicate noise reaching several years on some clocks, short-interval retesting measures the lab, not you.
• Treating one biological-age number as a diagnosis. The TranslAGE authors position these tools as trial endpoints under validation, not clinical verdicts.
• Waiting for a symptom to justify the checkup. In all three domains, symptoms mark the late, less reversible stage.

Where the evidence stands

Established: the prevalence figures for gum recession and periodontitis; the 30 percent global prevalence of steatotic liver disease; the reversibility of early liver disease through lifestyle change; FIB-4-based risk stratification; the unreliability of ALT alone.

Emerging: the periodontal-cardiovascular association (real but not proven causal); epigenetic clocks as responsive intervention biomarkers, with second-generation pace-of-aging clocks leading.

Personal experimentation: tracking your own DunedinPACE trend across yearly tests; correlating your periodontal chart or FIB-4 with specific habit changes. Worth doing if it motivates you; not yet something any guideline prescribes.

What to do this month

Book the periodontal charting, add AST and platelets to your next blood draw, and write down three numbers you currently do not know: your deepest pocket depth, your worst recession site, and your FIB-4. None of this requires new technology or new spending, and all of it converts "I feel fine" into data you can act on with your dentist and physician. Silent aging stays silent only as long as nobody asks it a question.

Sources